Healthcare professionals / Gastroenterology / HabibTM EndoHPB Bipolar Radiofrequency Catheter

Habib™ EndoHBP Bipolar Radiofrequency Catheter

The management of strictures related to pancreaticobiliary disease continues to be an area of exploration and opportunity for treating both malignant and benign disease.

The Habib™ EndoHPB Bipolar Radiofrequency Catheter is the first Radio Frequency (RF) ablation catheter indicated in Europe for malignant or benign tissue ablation in the pancreatic and biliary tract.

The Habib™ EndoHPB RF Catheter enables to perform:

  • Partial or complete ablation of malignant or benign tissue
  • Ablation in the pancreatic and biliary tracts
  • Endoscopic biliary drainage or decompression prior to stent placement or afterwards to clear an occluded stent.
     

The Habib™  Endo HPB Device is a widely used and published device for biliary ductal ablation with consistent results:

  • > 13.500 procedures
  • > 30 peer-reviewed published papers
  

About the Radiofrequency Ablation procedure with Habib™ EndoHBP Bipolar RF Catheter

HabibTM EndoHBP Bipolar RF Catheter has 8Fr (2.7mm) diameter, 180cm useable length and two stainless steel electrodes at the distal tip. The radio frequency is applied to both electrodes to heat the tissue surrounding the catheter.

HabibTM EndoHPB Catheter and Bipolar Adaptor Cables are compatible with most electrosurgical generators and potentially eliminates additional capital investment.

 
Download the product brochure
   

Habib™ EndoHBP Clinical Experience

As your hospital moves towards recovery after COVID-19, you need access to technologies that will help you and your department reduce waiting lists.

RFA with HabibTM EndoHPB Catheter is an efficient procedure that enables you to avoid repeat procedures by extending luminal patency for benign and malignant biliary strictures.

  • Endoscopic biliary radiofrequency ablation with the Habib™ EndoHPB prior to stent placement has been shown to prolong metallic biliary stent patency by 13%, from an average of 8.4 months to 9.5 months.1
  • Data shows that RFA with the Habib™ EndoHPB for occluded SEMS significantly improved mean stent patency time compared to plastic stent insertion and add when the stenosis was able to be eradicated to more than 80% of the stent diameter by RFA.2
  • Mean plastic stent patency was also longer for RFA and stent at 6.8 months compared to stenting alone at 3.4 months.3

The Habib EndoHPB also provides an option to restore biliary drainage in patients who may outlive the patency of their metallic biliary stents.2

Additionally, RFA is a safe and effective treatment option. A meta-analysis comparing biliary stenting with RFA to stenting alone did not show a significant difference with regard to risk of cholangitis, acute cholecystitis, pancreatitis, and hemobilia. However, RFA was associated with a higher risk of postprocedural abdominal pain.4

The effectiveness of this device for use in the treatment of pancreatic or biliary cancer or pancreatic or biliary disease (i.e. improved clinical outcomes) has not been established.
  

Click on the disease state for further information

Cholangiocarcinoma Stricture Management
Cholangiocarcinoma Stricture Management
Ampullary Ablation
Ampullary Neoplasm
Pancreatic Cancer Stricture Management
Pancreatic Cancer Stricture Management
 
Benign Ablation
Benign Ablation

 

 

Habib™ EndoHBP Bipolar Catheter: A Medical Innovation

In March 2020 the Habib™ EndoHBP Bipolar Radiofrequency Catheter has been recognized by the Edison Awards for making a meaningful difference for patients. The device received a Gold award in the Medical Innovations subcategory.
2020 Edison Awards
The Edison Awards, named for Thomas Edison, is an annual competition honoring excellence in new product and service development, marketing, human-centered design and innovation. Nominations receive an unbiased, high-powered, focus group review by the Edison Awards Steering Committee, comprised of hand-picked industry experts from a spectrum of disciplines.

Sources:

  1. Liang, H. et al., “Metal Stenting with or without Endobiliary Radiofrequency Ablation for Unresectable Extrahepatic Cholangiocarcinoma”, Journal of Cancer Therapy, October 2017
  2. Kadayifci, Abdurrahman et al. “Radiofrequency ablation for the management of occluded biliary metal stents.” Endoscopy vol. 48,12 (2016): 1096-1101. doi:10.1055/s-0042-115938
  3. Yang, Jianfeng et al. “Efficacy and safety of endoscopic radiofrequency ablation for unresectable extrahepatic cholangiocarcinoma: a randomized trial.” Endoscopy vol. 50,8 (2018): 751-760. doi:10.1055/s-0043-124870
  4. Sofi, Aijaz Ahmed et al. “Radiofrequency ablation combined with biliary stent placement versus stent placement alone for malignant biliary strictures: a systematic review and meta-analysis.” Gastrointestinal endoscopy vol. 87,4 (2018): 944-951.e1. doi:10.1016/j.gie.2017.10.029


All trademarks are the property of their respective owners.
CAUTION: The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings and instructions for use can be found in the product labelling supplied with each device.
Products shown for INFORMATION purposes only and may not be approved or for sale in certain countries. This material not intended for use in France.
Product available in the European Economic Area (EEA) only. Please check availability with your local sales representative or customer service.
Top